APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Follicle Stimulating Hormones (FSH)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Follicle Stimulating Hormones (FSH) Market Outlook and Growth Opportunities 2026

Report ID 174046070420 December 2025197 pages

Choose your research edition.

Industry ResearchVeterinary Follicle Stimulating Hormones (FSH) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Follicle Stimulating Hormones (FSH) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Veterinary Follicle Stimulating Hormones (FSH) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Follicle Stimulating Hormones (FSH) Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Follicle Stimulating Hormones (FSH) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Veterinary Follicle Stimulating Hormones (FSH) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Follicle Stimulating Hormones (FSH) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Follicle Stimulating Hormones (FSH) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Follicle Stimulating Hormones (FSH) market include Vetoquinol, Trophogen, Inc, SUMU, Ningbo Second Hormone Factory, MSD, Laboratorios HIPRA, S.A. and Calier, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Follicle Stimulating Hormones (FSH) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Follicle Stimulating Hormones (FSH) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Follicle Stimulating Hormones (FSH) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Follicle Stimulating Hormones (FSH) market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Follicle Stimulating Hormones (FSH) Segment by Company

Vetoquinol

Trophogen, Inc

SUMU

Ningbo Second Hormone Factory

MSD

Laboratorios HIPRA, S.A.

Calier

Veterinary Follicle Stimulating Hormones (FSH) Segment by Type

Serum Gonadotrophin and Chorionic Gonadotrophin

Chorionic Gonadotrophin

Folltropin

Others

Veterinary Follicle Stimulating Hormones (FSH) Segment by Application

Horse

Bovine

Sheep

Others

Veterinary Follicle Stimulating Hormones (FSH) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Veterinary Follicle Stimulating Hormones (FSH) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Follicle Stimulating Hormones (FSH) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Follicle Stimulating Hormones (FSH) significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Follicle Stimulating Hormones (FSH) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Follicle Stimulating Hormones (FSH) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Follicle Stimulating Hormones (FSH) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Follicle Stimulating Hormones (FSH).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Follicle Stimulating Hormones (FSH) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Follicle Stimulating Hormones (FSH) industry.

Chapter 3: Detailed analysis of Veterinary Follicle Stimulating Hormones (FSH) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Follicle Stimulating Hormones (FSH) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Follicle Stimulating Hormones (FSH) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Follicle Stimulating Hormones (FSH) Industry Trends Table 2. Veterinary Follicle Stimulating Hormones (FSH) Industry Drivers Table 3. Veterinary Follicle Stimulating Hormones (FSH) Industry Opportunities and Challenges Table 4. Veterinary Follicle Stimulating Hormones (FSH) Industry Restraints Table 5. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Follicle Stimulating Hormones (FSH) Revenue Share by Company (2021-2026) Table 7. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Follicle Stimulating Hormones (FSH) Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Veterinary Follicle Stimulating Hormones (FSH) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Follicle Stimulating Hormones (FSH) Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Follicle Stimulating Hormones (FSH) Company, Product Type & Application Table 13. Global Veterinary Follicle Stimulating Hormones (FSH) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Follicle Stimulating Hormones (FSH) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Serum Gonadotrophin and Chorionic Gonadotrophin Table 18. Significant Companies of Chorionic Gonadotrophin Table 19. Significant Companies of Folltropin Table 20. Significant Companies of Others Table 21. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Type (2021-2026) Table 25. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Type (2027-2032) Table 26. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type (2021-2026) Table 30. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Horse Table 32. Significant Companies of Bovine Table 33. Significant Companies of Sheep Table 34. Significant Companies of Others Table 35. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Application (2021-2026) Table 39. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Application (2027-2032) Table 40. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application (2021-2026) Table 44. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application (2027-2032) Table 45. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2021-2026) & (K Units) Table 47. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Region (2021-2026) Table 48. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2027-2032) & (K Units) Table 49. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Region (2027-2032) Table 50. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Region (2021-2026) Table 53. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Region (2027-2032) Table 55. Global Veterinary Follicle Stimulating Hormones (FSH) Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Veterinary Follicle Stimulating Hormones (FSH) Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2026) & (K Units) Table 60. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Country (2021-2026) Table 61. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2027-2032) & (K Units) Table 62. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Country (2027-2032) Table 63. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Market Share by Country (2021-2026) Table 65. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Market Share by Country (2027-2032) Table 67. Vetoquinol Company Information Table 68. Vetoquinol Business Overview Table 69. Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 71. Vetoquinol Recent Development Table 72. Trophogen, Inc Company Information Table 73. Trophogen, Inc Business Overview Table 74. Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 76. Trophogen, Inc Recent Development Table 77. SUMU Company Information Table 78. SUMU Business Overview Table 79. SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 81. SUMU Recent Development Table 82. Ningbo Second Hormone Factory Company Information Table 83. Ningbo Second Hormone Factory Business Overview Table 84. Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 86. Ningbo Second Hormone Factory Recent Development Table 87. MSD Company Information Table 88. MSD Business Overview Table 89. MSD Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. MSD Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 91. MSD Recent Development Table 92. Laboratorios HIPRA, S.A. Company Information Table 93. Laboratorios HIPRA, S.A. Business Overview Table 94. Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 96. Laboratorios HIPRA, S.A. Recent Development Table 97. Calier Company Information Table 98. Calier Business Overview Table 99. Calier Veterinary Follicle Stimulating Hormones (FSH) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Calier Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio Table 101. Calier Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Veterinary Follicle Stimulating Hormones (FSH) Distributors List Table 105. Veterinary Follicle Stimulating Hormones (FSH) Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Veterinary Follicle Stimulating Hormones (FSH) Product Image Figure 2. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Follicle Stimulating Hormones (FSH) Sales (2021-2032) & (K Units) Figure 5. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Veterinary Follicle Stimulating Hormones (FSH) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Serum Gonadotrophin and Chorionic Gonadotrophin Image Figure 10. Chorionic Gonadotrophin Image Figure 11. Folltropin Image Figure 12. Others Image Figure 13. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Type (2021-2032) Figure 16. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type (2021-2032) Figure 19. Horse Image Figure 20. Bovine Image Figure 21. Sheep Image Figure 22. Others Image Figure 23. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Application (2021-2032) Figure 26. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application (2021-2032) Figure 29. Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Veterinary Follicle Stimulating Hormones (FSH) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Veterinary Follicle Stimulating Hormones (FSH) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Gonadotrophin and Chorionic Gonadotrophin
  • Chorionic Gonadotrophin
  • Folltropin
  • Others
Applications
  • Horse
  • Bovine
  • Sheep
  • Others
Companies covered
  • Vetoquinol
  • Trophogen, Inc
  • SUMU
  • Ningbo Second Hormone Factory
  • MSD
  • Laboratorios HIPRA, S.A.
  • Calier

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Follicle Stimulating Hormones (FSH) Market Dynamics
  1. 2.1 Veterinary Follicle Stimulating Hormones (FSH) Industry Trends
  2. 2.2 Veterinary Follicle Stimulating Hormones (FSH) Industry Drivers
  3. 2.3 Veterinary Follicle Stimulating Hormones (FSH) Industry Opportunities and Challenges
  4. 2.4 Veterinary Follicle Stimulating Hormones (FSH) Industry Restraints
3 Veterinary Follicle Stimulating Hormones (FSH) Market by Company
  1. 3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Follicle Stimulating Hormones (FSH) Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Follicle Stimulating Hormones (FSH) Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Follicle Stimulating Hormones (FSH) Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Follicle Stimulating Hormones (FSH) Company Product Type and Application
  8. 3.8 Global Veterinary Follicle Stimulating Hormones (FSH) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Follicle Stimulating Hormones (FSH) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Follicle Stimulating Hormones (FSH) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Follicle Stimulating Hormones (FSH) Market by Type
  1. 4.1 Veterinary Follicle Stimulating Hormones (FSH) Type Introduction
  2. 4.1.1 Serum Gonadotrophin and Chorionic Gonadotrophin
  3. 4.1.2 Chorionic Gonadotrophin
  4. 4.1.3 Folltropin
  5. 4.1.4 Others
  6. 4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type
  7. 4.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type
  11. 4.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type (2021-2032)
5 Veterinary Follicle Stimulating Hormones (FSH) Market by Application
  1. 5.1 Veterinary Follicle Stimulating Hormones (FSH) Application Introduction
  2. 5.1.1 Horse
  3. 5.1.2 Bovine
  4. 5.1.3 Sheep
  5. 5.1.4 Others
  6. 5.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application
  7. 5.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application
  11. 5.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application (2021-2032)
6 Veterinary Follicle Stimulating Hormones (FSH) Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Follicle Stimulating Hormones (FSH) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Country, 2025 VS 2032
7 Veterinary Follicle Stimulating Hormones (FSH) Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Follicle Stimulating Hormones (FSH) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Follicle Stimulating Hormones (FSH) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Vetoquinol
  2. 8.1.1 Vetoquinol Company Information
  3. 8.1.2 Vetoquinol Business Overview
  4. 8.1.3 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Vetoquinol Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  6. 8.1.5 Vetoquinol Recent Developments
  7. 8.2 Trophogen, Inc
  8. 8.2.1 Trophogen, Inc Company Information
  9. 8.2.2 Trophogen, Inc Business Overview
  10. 8.2.3 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Trophogen, Inc Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  12. 8.2.5 Trophogen, Inc Recent Developments
  13. 8.3 SUMU
  14. 8.3.1 SUMU Company Information
  15. 8.3.2 SUMU Business Overview
  16. 8.3.3 SUMU Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SUMU Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  18. 8.3.5 SUMU Recent Developments
  19. 8.4 Ningbo Second Hormone Factory
  20. 8.4.1 Ningbo Second Hormone Factory Company Information
  21. 8.4.2 Ningbo Second Hormone Factory Business Overview
  22. 8.4.3 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ningbo Second Hormone Factory Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  24. 8.4.5 Ningbo Second Hormone Factory Recent Developments
  25. 8.5 MSD
  26. 8.5.1 MSD Company Information
  27. 8.5.2 MSD Business Overview
  28. 8.5.3 MSD Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MSD Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  30. 8.5.5 MSD Recent Developments
  31. 8.6 Laboratorios HIPRA, S.A.
  32. 8.6.1 Laboratorios HIPRA, S.A. Company Information
  33. 8.6.2 Laboratorios HIPRA, S.A. Business Overview
  34. 8.6.3 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Laboratorios HIPRA, S.A. Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  36. 8.6.5 Laboratorios HIPRA, S.A. Recent Developments
  37. 8.7 Calier
  38. 8.7.1 Calier Company Information
  39. 8.7.2 Calier Business Overview
  40. 8.7.3 Calier Veterinary Follicle Stimulating Hormones (FSH) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Calier Veterinary Follicle Stimulating Hormones (FSH) Product Portfolio
  42. 8.7.5 Calier Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Follicle Stimulating Hormones (FSH) Value Chain Analysis
  2. 9.1.1 Veterinary Follicle Stimulating Hormones (FSH) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Follicle Stimulating Hormones (FSH) Sales Mode & Process
  6. 9.2 Veterinary Follicle Stimulating Hormones (FSH) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Follicle Stimulating Hormones (FSH) Distributors
  9. 9.2.3 Veterinary Follicle Stimulating Hormones (FSH) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst